🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/05/1997 | 43,83 | 44,55 | 43,83 | 44,37 | +1,78% | 1,63% | 2.863.974 |
| 22/05/1997 | 44,55 | 44,67 | 43,59 | 43,59 | -1,62% | 2,41% | 3.295.541 |
| 21/05/1997 | 44,79 | 45,15 | 44,01 | 44,31 | -0,27% | 2,53% | 6.489.006 |
| 20/05/1997 | 43,71 | 44,61 | 43,06 | 44,43 | +1,09% | 3,55% | 6.319.230 |
| 19/05/1997 | 43,48 | 44,37 | 43,06 | 43,95 | +0,96% | 3,02% | 4.121.574 |
| 16/05/1997 | 44,49 | 44,85 | 43,48 | 43,54 | -2,54% | 3,08% | 6.747.653 |
| 15/05/1997 | 44,25 | 44,79 | 44,13 | 44,67 | +1,08% | 1,48% | 4.423.608 |
| 14/05/1997 | 44,55 | 44,61 | 44,01 | 44,19 | +0,14% | 1,34% | 3.923.293 |
| 13/05/1997 | 44,49 | 44,67 | 43,71 | 44,13 | -0,13% | 2,14% | 7.569.494 |
| 12/05/1997 | 43,12 | 44,25 | 43,06 | 44,19 | +2,63% | 2,77% | 5.712.229 |
| 09/05/1997 | 42,70 | 43,30 | 42,34 | 43,06 | +1,69% | 2,23% | 4.773.640 |
| 08/05/1997 | 42,58 | 43,54 | 42,34 | 42,34 | -0,84% | 2,80% | 5.198.709 |
| 07/05/1997 | 43,95 | 44,13 | 42,58 | 42,70 | -2,72% | 3,53% | 4.541.403 |
| 06/05/1997 | 43,65 | 44,43 | 43,65 | 43,89 | +0,55% | 1,78% | 7.872.786 |
| 05/05/1997 | 43,54 | 44,07 | 43,12 | 43,65 | +0,55% | 2,19% | 6.822.690 |
| 02/05/1997 | 42,58 | 43,48 | 42,52 | 43,42 | +2,25% | 2,24% | 5.674.291 |
| 01/05/1997 | 43,00 | 43,42 | 42,34 | 42,46 | -1,52% | 2,50% | 5.152.597 |
| 30/04/1997 | 43,36 | 43,83 | 42,94 | 43,12 | -1,23% | 2,06% | 7.388.610 |
| 29/04/1997 | 42,88 | 43,77 | 42,64 | 43,65 | +3,10% | 2,64% | 6.079.658 |
| 28/04/1997 | 41,87 | 42,52 | 41,75 | 42,34 | +1,57% | 1,85% | 3.775.525 |
| 25/04/1997 | 41,51 | 41,87 | 41,33 | 41,69 | +0,29% | 1,29% | 3.040.248 |
| 24/04/1997 | 42,04 | 42,22 | 41,21 | 41,57 | -0,71% | 2,41% | 4.383.994 |
| 23/04/1997 | 42,58 | 42,64 | 41,81 | 41,87 | -1,68% | 1,96% | 6.002.944 |
| 22/04/1997 | 41,45 | 42,70 | 41,33 | 42,58 | +3,18% | 3,31% | 6.778.883 |
| 21/04/1997 | 41,39 | 41,75 | 40,85 | 41,27 | -0,14% | 2,16% | 4.474.541 |
| 18/04/1997 | 41,15 | 41,45 | 40,79 | 41,33 | +0,43% | 1,59% | 5.724.176 |
| 17/04/1997 | 40,79 | 41,33 | 40,55 | 41,15 | +0,73% | 1,90% | 5.867.542 |
| 16/04/1997 | 40,43 | 41,15 | 40,08 | 40,85 | +1,33% | 2,65% | 7.143.797 |
| 15/04/1997 | 39,96 | 40,43 | 39,60 | 40,31 | +2,27% | 2,09% | 7.630.698 |
| 14/04/1997 | 38,94 | 39,54 | 38,47 | 39,42 | +1,07% | 2,76% | 6.538.472 |